Phase I study of high-dose ifosfamide, carboplatin and etoposide with autologous hematopoietic stem cell support

Bone Marrow Transplantation

Volumn 15, Issue 3, 1995, Pages 373-379

  Elias, A D ^a   Ayash, L J ^a   Wheeler, C ^a   Schwartz, G ^a   Tepler, I ^a   Gonin, R ^a   McCauley, M ^a   Mazanet, R ^a   Schnipper, L ^a   Frei III, E ^a   Antman, K H ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

High dose ICE; Stem cell support

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; ETOPOSIDE; IFOSFAMIDE;

ADULT; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER COMBINATION CHEMOTHERAPY; CLINICAL TRIAL; CONFUSION; CREATININE BLOOD LEVEL; DIARRHEA; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG TOLERANCE; FEMALE; GASTROINTESTINAL SYMPTOM; HEMATOPOIETIC STEM CELL; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MUCOSA INFLAMMATION; MULTIMODALITY CANCER THERAPY; NEPHROTOXICITY; NEUROTOXICITY; PATIENT MONITORING; PHASE 1 CLINICAL TRIAL; PRIORITY JOURNAL; SOMNOLENCE;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; COMBINED MODALITY THERAPY; ETOPOSIDE; FEMALE; GASTROINTESTINAL SYSTEM; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IFOSFAMIDE; MALE; MIDDLE AGE; NEOPLASMS, GERM CELL AND EMBRYONAL; NERVOUS SYSTEM; OVARIAN NEOPLASMS; SARCOMA; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; SURVIVAL RATE; TESTICULAR NEOPLASMS; TRANSPLANTATION, AUTOLOGOUS;

EID: 0028960806     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (0)